Hebei Jingye Group

What they make

1 input Hebei Jingye Group supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

• Did you know2024

  Salicylic acid from Chinese producers like Hebei Jingye simultaneously supplies: the global aspirin API market (aspirin is the most widely consumed pharmaceutical in the world, ~40,000 tonnes/year), the acne treatment skincare market (Stridex, Clearasil, and virtually all salicylic acid acne pads, washes, and serums), and industrial uses including sodium salicylate (a UV absorber in plastics) and methyl salicylate (oil of wintergreen topical pain relievers). The pharmaceutical grade, cosmetic grade, and industrial grade versions are all produced from the same Kolbe-Schmitt synthesis route — differentiated by purity specification and testing. A Chinese salicylic acid production disruption (from environmental regulation, a factory accident, a China-US trade restriction on pharmaceutical ingredients, or a plant explosion) would simultaneously affect aspirin availability at pharmacies, acne treatment product availability at drug stores, and industrial chemical supply chains — three completely separate consumer/industrial markets supplied from the same upstream Chinese production base.

  U.S. Food and Drug Administration ↗

• Concentration2021

  China produces approximately 80-90% of global salicylic acid, making it the dominant source of the primary precursor for the world's most consumed pharmaceutical — aspirin. The US imports the vast majority of its aspirin API (acetylsalicylic acid) and its salicylic acid intermediate from China. While aspirin itself was invented in Germany and for decades was primarily manufactured in Western countries, production has systematically migrated to China as lower production costs and China's phenol/chemical industry scale advantages prevailed. US and European pharmaceutical manufacturers are largely dependent on Chinese salicylic acid for their aspirin production. The pharmaceutical ingredient concentration in China, demonstrated most dramatically with antibiotics (90%+ of amoxicillin and penicillin API) and vitamin C (90%+ of world supply), extends to aspirin's chemistry — the oldest and most trusted pharmaceutical molecule in the world is now supply-chain-dependent on Chinese chemical production capacity.

  U.S. International Trade Commission ↗

• Origin2012

  Salicylic acid's journey from willow bark to Hebei Province chemical plants is one of pharmaceutical chemistry's great origin stories. The Sumerians used willow bark for fever and pain relief 4,000 years ago; 19th-century chemists isolated salicin as the active compound; and Hermann Kolbe's 1859 Kolbe-Schmitt synthesis of salicylic acid from sodium phenolate and CO₂ enabled industrial production. Today, China's Hebei Province is the world's dominant salicylic acid production center, with Hebei Jingye Group and Shandong Xinhua Pharmaceutical among the major producers supplying the global aspirin industry. The Kolbe-Schmitt process that Kolbe developed in Marburg, Germany in 1859 is still the production route used in Hebei chemical plants — essentially unchanged chemistry operating in a completely different geopolitical and economic context than any 19th-century German chemist could have imagined.

  NCBI / Biochemical Pharmacology ↗